BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 5:33:00 PM | Browse: 1304 | Download: 1066
Publication Name World Journal of Gastroenterology
Manuscript ID 6106
Country China
Received
2013-10-03 17:34
Peer-Review Started
2013-10-03 18:53
To Make the First Decision
2013-10-22 16:16
Return for Revision
2013-10-23 19:39
Revised
2013-11-02 01:26
Second Decision
2013-11-18 20:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-19 12:10
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-12-12 10:30
Typeset the Manuscript
2013-12-29 19:43
Publish the Manuscript Online
2014-01-20 17:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Autobiography
Article Title Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma
Manuscript Source Invited Manuscript
All Author List Ming-Ming He, Dong-Sheng Zhang, Feng Wang, Zhi-Qiang Wang, Hui-Yan Luo, Chao Ren, Ying Jin, Dong-Liang Chen and Rui-Hua Xu
Funding Agency and Grant Number
Funding Agency Grant Number
National High-tech R&D Program of China (863 Program) 2012AA02A506
Science and Technology Department of Guangdong Province, China 2012B031800088
Medical Scientific Research Foundation of Guangdong Province, China C2011019
Corresponding Author Rui-Hua Xu, MD, PhD, Professor, Vice-President, State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng East Road, Guangzhou 510060, Guangdong Province, China. xurh@sysucc.org.cn
Key Words Gastric adenocarcinoma; Adjuvant chemotherapy; p53; Carcinoembryonic antigen; Immunohistochemistry
Core Tip Patients after D2 gastrectomy for stage Ⅱ/Ⅲ gastric adenocarcinoma had a significant survival benefit after adjuvant chemotherapy compared with surgery alone, which was maintained when restricted to stage Ⅱ, Ⅲ or ⅢB/ⅢC patients. The survival did not differ significantly between the patients with p53(+) and p53(-) tumors, or between patients with carcinoembryonic antigen (CEA)(+) and CEA(-) tumors, which were maintained when the analyses were restricted to surgery alone, adjuvant chemotherapy and even different chemotherapy regimens. p53 and CEA immunohistochemical expression is not prognostic for survival after D2 gastrectomy.
Publish Date 2014-01-20 17:10
Citation He MM, Zhang DS, Wang F, Wang ZQ, Luo HY, Ren C, Jin Y, Chen DL, Xu RH. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma. World J Gastroenterol 2014; 20(1): 264-273
URL http://www.wjgnet.com/1007-9327/full/v20/i1/264.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i1.264
Full Article (PDF) WJG-20-264.pdf
Full Article (Word) WJG-20-264.doc
Manuscript File 6106-Review.doc
Answering Reviewers 6106-Answering Reviewers.pdf
Copyright License Agreement 6106-Copyright Assignment.pdf
Non-Native Speakers of English Editing Certificate 6106-Language certificate.PDF
Peer-review Report 6106-Peer review(s).pdf
Scientific Editor Work List 6106-Scientific editor work list.doc